Stelvio Therapeutics' Seed Round

Stelvio Therapeutics raised a round of funding on September 12, 2017. Investors include IndieBio.

Stelvio Therapeutics, aka Stelvio Oncology, is a biotechnology company that focuses on developing a pipeline of alternative treatments for malignant glioblastoma multiforme (GBM), the most common and …

Articles about Stelvio Therapeutics' Seed Round: